期刊文献+

冠脉支架术后接受双联抗血小板聚集药物治疗患者消化道出血危险因素分析 被引量:8

Analysis of risk factors for alimentary tract hemorrhage in patients treated by dual antiplatelet drugs after coronary stent operation
下载PDF
导出
摘要 目的通过对接受双联抗血小板聚集药物治疗的冠脉支架术后患者资料进行回顾性分析,明确消化道出血的相关危险因素。方法 960例冠脉支架植入术后服用双联抗血小板药物患者,通过电话或门诊随访方式收集患者资料,以是否出现消化道出血为因变量(是=1,否=0),以年龄(≥65岁=1;<65岁=0)、性别(男=1,女=0)以及吸烟史、服用华法林、肌酐清除率下降、联用质子泵抑制剂(PPI)、饮酒史、消化道疾病病史、糖尿病病史、左室射血分数下降(有=1,无=0)等为自变量进行多因素回归分析。结果 960例冠脉支架植入术后服用双联抗血小板药物患者中有46例(4.79%)出现消化道出血事件,分析显示:老年(≥65岁)、有吸烟史、服用华法林、肌酐清除率下降、有饮酒史、有消化道疾病病史、左室射血分数下降为冠脉支架植入术后接受双联抗血小板聚集药物治疗患者消化道出血的危险因素(P<0.05),而联用PPI为冠脉支架植入术后接受双联抗血小板聚集药物治疗患者消化道出血的保护因素(P<0.05)。结论双联抗血小板聚集药物治疗的冠脉支架术后患者消化道出血高危因素包括老年(≥65岁)、有吸烟史、服用华法林、肌酐清除率下降、有饮酒史、有消化道疾病病史、左室射血分数下降等。 Objective To clarify related risk factors for alimentary tract hemorrhage by retrospectively analyzing clinical data of patients treated by dual antiplatelet drugs after coronary stent operation. Methods There were 960 coronary stent operation patients treated with dual antiplatelet drugs after operation, and their clinical data were collected by telephone or outpatient follow-up. Multivariate regression analysis was taken along with whether alimentary tract hemorrhage or not as dependent variable(with=1, without=0) and age( ≥ 65 years old=1, 65 years old=0), gender(male=1, female=0), smoking history, warfarin administration, reduced creatinine clearance rate, proton pump inhibitor(PPI) combination, alcohol intaking history, alimentary tract disease history, diabetes history and reduced left ventricular ejection fraction(with=1, without=0) as independent variables. Results Among 960 patients treated by dual antiplatelet drugs after coronary stent operation, there were 46 cases(4.79%) with alimentary tract hemorrhage. Analysis showed elder age(≥65 years old), smoking history, warfarin administration, reduced creatinine clearance rate, alcohol intaking history, alimentary tract disease history, and reduced left ventricular ejection fraction as risk factors for alimentary tract hemorrhage in patients treated by dual antiplatelet drugs after coronary stent operation(P〈0.05), while PPI combination was shown as protective factor for alimentary tract hemorrhage in patients treated by dual antiplatelet drugs after coronary stent operation(P〈0.05). Conclusion High risk factors for alimentary tract hemorrhage in patients treated by dual antiplatelet drugs after coronary stent operation include elder age( ≥ 65 years old), smoking history, warfarin administration, reduced creatinine clearance rate, alcohol intaking history, alimentary tract disease history, and reduced left ventricular ejection fraction.
作者 赵洪磊 罗颖 范爱玲 彭丽蓉 曾繁芳 龙娟 王丽丽 ZHAO Hong-lei LUO Ying FAN Ai-ling et al(Department of Cardiology, Shenzhen City Sun Yat-sen Angiocardiopathy Hospital, Shenzhen 518112, China)
出处 《中国实用医药》 2017年第3期18-20,共3页 China Practical Medicine
关键词 双联抗血小板药物 消化道出血 危险因素 Dual antiplatelet drugs Alimentary tract hemorrhage Risk factors
  • 相关文献

参考文献10

二级参考文献148

  • 1韩雅玲.中国经皮冠状动脉介入治疗指南2012(简本)[J].中国医学前沿杂志(电子版),2012,4(12):50-59. 被引量:133
  • 2Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 3Iakovou I,Schmidt T, Bonizzoni E,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA, 2005,293 : 2126-2130.
  • 4Holmes DR, Kereiakes D J, Laskey WK, et al. Thrombosis and drug-eluting stents: an objective appraisal. J Am Coll Cardiol, 2007,50 : 109-118.
  • 5Grines CL,Bonow RO, Casey DE,et al. American Heart Association,American College of Cardiology,Society for Cardiovascular Angiography and Interventions,American College of Surgeons, American Dental Association,American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation, 2007,115 : 813-818.
  • 6Cutlip DE,Baim DS,Ho KK,et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation, 2001,103 : 1967-1971.
  • 7Wang F, Stouffer GA, Waxman S, et al. Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era.Catheter Cardiovase Interv , 2002,55 : 142-147.
  • 8Smith SC,Feldman TE,Hirshfeld JW,et ah ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Interventionsummary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention ). Circulation, 2006, 113 : 156-175.
  • 9Lagerqvist B, James SK,Stenestrand U,et al. Long-term outcomes with drugeluting stertts versus bare-metal stents in Sweden. N Engl J Med, 2007,356 : 1009-1019.
  • 10Pfisterer M,Brunner-La Rocca HP,Buser PT,et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol, 2006,48 : 2584-2591.

共引文献127

同被引文献64

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部